Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Plus Therapeutics Announces FDA Clearance Of Investigational New Drug Application For 186RNL For Treatment Of Leptomeningeal Metastases


Benzinga | Oct 19, 2021 07:32AM EDT

Plus Therapeutics Announces FDA Clearance Of Investigational New Drug Application For 186RNL For Treatment Of Leptomeningeal Metastases






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC